Medicxi bankrolls the launch of a pair of biotech twins focused on orexins for narcolepsy and more
The venture investors at Medicxi are funding a pair of biotech spinouts from UK-based Sosei Heptares, which has been fine tuning its expertise in G …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
